NCT03951636

Brief Summary

Peri-implant mucositis is an important disease entity as a result of its high prevalence and the lack of a standard mode of therapy. Non-surgical therapy of peri-implant mucositis appears to be partially effective in resolving the disease. In several cases, however, only limited improvements have been reported in the main clinical parameters (bleeding partial resolution and presence of pocket at follow-up visits) and there is a clear tendency to relapse of the disease. In these cases it is therefore recommended to consider adjunctive therapies. Numerous approaches have been used for implant surface decontamination including mechanical, chemical and treatments by means of air-powder or laser. The aim of the present randomized controlled clinical trial will be to assess the efficacy in improving clinical parameters of two further methods of implant surface decontamination (Er:YAG laser or air-abrasive device) after mechanical cleaning during non surgical treatment of peri-implant mucositis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 14, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 15, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

July 2, 2019

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 16, 2022

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 27, 2022

Completed
Last Updated

March 3, 2023

Status Verified

February 1, 2023

Enrollment Period

2.5 years

First QC Date

May 14, 2019

Last Update Submit

February 28, 2023

Conditions

Keywords

peri-implant mucositisnon surgical therapylaserair powder

Outcome Measures

Primary Outcomes (1)

  • Bleeding on probing changes

    changes of bleeding on probing, evaluated as present if bleeding will be evident within 30 s after probing, or absent, if no bleeding will be noticed within 30 s after probing

    baseline, 1, 3, 6 months

Secondary Outcomes (4)

  • probing pocket depth changes

    baseline, 1, 3, 6 months

  • mucosal recession changes

    baseline, 1, 3, 6 months

  • clinical attachment level changes

    baseline, 1, 3, 6 months

  • complete disease resolution (percentage)

    6 months

Study Arms (3)

Mechanical debridement with curettes

SHAM COMPARATOR

mechanical debridement: Inflammatory tissue, excess cement or plaque deposits will be removed using hand instruments

Procedure: Mechanical debridement with curettes

Er:YAG laser

EXPERIMENTAL

Er:YAG laser treatment will be provided on the implant/abutment surface.

Procedure: Er:YAG laser

Air Powder

ACTIVE COMPARATOR

an Air-Powder treatment will be provided on the implant/abutment surface.

Procedure: Air Powder

Interventions

mechanical debridement: Inflammatory tissue, excess cement or plaque deposits will be removed using hand instruments

Mechanical debridement with curettes
Er:YAG laserPROCEDURE

mechanical debridement: Inflammatory tissue, excess cement or plaque deposits will be removed using hand instruments. Furthermore, an Er:YAG laser will be used for the implant surface decontamination.

Er:YAG laser
Air PowderPROCEDURE

mechanical debridement: Inflammatory tissue, excess cement or plaque deposits will be removed using hand instruments. Furthermore, an Air-Powder treatment will be provided on the implant/abutment surface.

Air Powder

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • presence of at least one screw-type titanium implant exhibiting bleeding and/or suppuration on probing combined without progressive radiographic bone loss (compared to crestal bone levels at the time of placement of the reconstruction)or \<3mm bone level
  • single tooth and bridgework restorations without overhangings
  • no evidence of occlusal overload (i.e. occlusal contacts revealed appropriate adjustment)
  • implant function time ≥ 1 year

You may not qualify if:

  • Patients with uncontrolled diabetes
  • patients with osteoporosis or under bisphosphonate medication,
  • pregnant or lactating women,
  • patients with a history of radiotherapy to the head and neck region
  • patients with incapability to perform basal oral hygiene measures due to physical or mental disorders
  • hollow implants
  • implant mobility
  • implants at which no position could be identified where proper probing measurements could be performed;
  • previous surgical treatment of the peri-implantitis lesions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Università Vita-Salute San Raffaele

Milan, 20100, Italy

Location

MeSH Terms

Interventions

Lasers, Solid-State

Intervention Hierarchy (Ancestors)

LasersOptical DevicesEquipment and SuppliesRadiation Equipment and Supplies

Study Officials

  • Massimo De Sanctis

    Università Vita-Salute San Raffaele

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 14, 2019

First Posted

May 15, 2019

Study Start

July 2, 2019

Primary Completion

January 16, 2022

Study Completion

July 27, 2022

Last Updated

March 3, 2023

Record last verified: 2023-02

Locations